Related Experiment Videos
Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin
H E Witkowska1, B H Lubin, Y Beuzard
1Children's Hospital Oakland Research Institute, Calif. 94609.
The New England Journal of Medicine
|October 17, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A role for surgery in the treatment of relapsed Hodgkin lymphoma.
Pediatric blood & cancer·2018
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.
British journal of cancer·2013
Generalized schemes for high-throughput manipulation of the Desulfovibrio vulgaris genome.
Applied and environmental microbiology·2011
Death switch for gene therapy: application to erythropoietin transgene expression.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2010
Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes.
The New England journal of medicine·2026
Adult Attention Deficit-Hyperactivity Disorder.
The New England journal of medicine·2026
Long-Acting HIV Therapy in African Adults with Adherence Challenges.
The New England journal of medicine·2026
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis.
The New England journal of medicine·2026
Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.
The New England journal of medicine·2026
Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury.
The New England journal of medicine·2026
Platelet Dysfunction in Liver and Kidney Disease.
Hematology/oncology clinics of North America·2026
A New HOPE for Hypoplastic Left Heart Syndrome: Technique for Primary En-Bloc Heart and Aorta Transplant with Hypothermic Oxygenated Recovery of a DCD Heart.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Lipids, lipid-modifying drug targets with venous thromboembolism: a mendelian randomization study.
Clinics (Sao Paulo, Brazil)·2026